Clinical trial
A Phase 2a, Randomized, Double-Blind, Placebo Controlled, Dose Ranging, Multicenter Study to Determine the Safety, Tolerance, and Efficacy of Larazotide Acetate (AT-1001) in Celiac Disease Subjects During Gluten Challenge.
NCT00362856 is registered in ClinicalTrials.gov with 9 Meters Biopharma, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 2a, Randomized, Double-Blind, Placebo Controlled, Dose Ranging, Multicenter Study to Determine the Safety, Tolerance, and Efficacy of Larazotide Acetate (AT-1001) in Celiac Disease Subjects During Gluten Challenge.
- Lead sponsor
- 9 Meters Biopharma, Inc.
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- September 13, 2006
- Completion date
- March 6, 2007
- Enrollment
- 80 (actual)
- Sites
- 9
Conditions
As the registry lists them; a condition with its own page is linked.